Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07114042

HALP as a Novel Score for Prediction of Mortality and re_bleeding in Upper GIT Bleeding

Evaluation of the prognostic utility of the HALP score in patients with upper gastrointestinal bleeding, particularly in predicting re_bleeding risk and mortality in internal medicine department in Sohag University Hospitals.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Upper Gastrointestinal Bleeding Digestive System Diseases Gastrointestinal Diseases Gastrointestinal Hemorrhage Hemorrhage Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Study for evaluation of the utility of hemoglobin, Albumin, Lymphocyte and Platelat score in prediction of mortality and re_bleeding in patient with upper gastrointestinal bleeding, Patients will be included if they were initially admitted to the emergency department, had a confirmed diagnosis of upper gastrointestinal bleeding via endoscopy, and were 18 years of age or older.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients will be included if they were initially admitted to the emergency department, had a confirmed diagnosis of upper gastrointestinal bleeding via endoscopy, and were 18 years of age or older.

Exclusion criteria

  • Incomplete clinical data.
  • Lack of laboratory results obtained at emergency department admission necessary for the calculation of HALP score; albumin, hemoglobin (HGB), platelets (PLT), or international normalized ratio (INR).
  • Pregnancy
  • Patients with missing data on clinical outcomes

Treatment and study plan

Upper endoscopy

Diagnostic Test

Prediction of upper gastrointestinal r_bleeding and mortality

Primary outcomes

  1. "Mortality"

    Time frame: 6 months

  2. Incidence of "Re_bleeding"

    Time frame: 6 months

Study contacts

Contact information is provided by the study sponsor or research team.

Reham R Baeoumy, Master

CONTACT

[email protected]

0106 3367488

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Moglobin, Albumin, Lymphocyte and Platelet Score as a Novel Predictor of Mortality and Re-bleeding in Patients With Upper Gastrointestinal Bleeding

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 11, 2025
Registry last updated
Aug 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.